RILETAMOTIDE
UNII DY1CEF6QAN

Substance Identification & Data

This profile provides standardized clinical and technical data for Riletamotide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DY1CEF6QAN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 524061-04-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
DY1CEF6QAN
CAS Registry Number
524061-04-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RILETAMOTIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C184842
National Cancer Institute reference terminology for clinical and research data.
INN ID
11692
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Riletamotide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RILETAMOTIDE

Common Names & Synonyms

H-ALA-GLU-ARG-LEU-THR-SER-ARG-VAL-LYS-ALA-LEU-PHE-SER-VAL-LEU-OH
P-728
RILETAMOTIDE [INN]
TELOMERASE REVERSE TRANSCRIPTASE 651-665 PEPTIDE ANTIGEN
UV1 COMPONENT TELOMERASE REVERSE TRANSCRIPTASE 651-665 PEPTIDE ANTIGEN

Systematic Nomenclature

L-LEUCINE, L-ALANYL-L-.ALPHA.-GLUTAMYL-L-ARGINYL-L-LEUCYL-L-THREONYL-L-SERYL-L-ARGINYL-L-VALYL-L-LYSYL-L-ALANYL-L-LEUCYL-L-PHENYLALANYL-L-SERYL-L-VALYL-

Technical Codes

P728

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus